You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,376,661


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,376,661
Title:Opening element for opening an ampoule in an aerosol generation device and aerosol generation device comprising the opening element
Abstract: An opening element for opening an ampoule in an aerosol generation device includes a first member which has a conduit extending therethrough for guiding a fluid contained in the ampoule through the first member and a second member which is arranged at least partly inside or on the conduit. Further, an aerosol generation device includes such an opening element.
Inventor(s): Gallem; Thomas (Munich, DE), Hetzer; Uwe (Munich, DE), Pham; Stephen (San Diego, CA), Quintana; Reynaldo (Menlo Park, CA)
Assignee: PARI Pharma GmbH (Starnberg, DE)
Application Number:14/427,457
Patent Claim Types:
see list of patent claims
Delivery; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of U.S. Patent 10,376,661

Introduction

Patents are a crucial component of intellectual property, providing inventors and innovators with exclusive rights to their creations. To delve into the specifics of a U.S. patent, we will analyze U.S. Patent 10,376,661, exploring its scope, claims, and the broader patent landscape.

What is a Patent?

A patent is a grant of rights for an invention, given by the government to the inventor, allowing them to exclude others from making, using, or selling the invention for a specified period, usually 20 years from the filing date[4].

The Patent Act and Eligibility

The U.S. Patent Act, specifically Section 101, outlines what can be patented: "any new and useful process, machine, manufacture, or composition of matter, or any improvement thereof." However, certain exceptions exist, such as laws of nature, natural phenomena, and abstract ideas, which are not patentable[2].

The Alice Test

To determine if a patent claim is directed to patent-ineligible subject matter, the Supreme Court's Alice test is applied. This two-step test first determines if the claims are directed to an abstract idea. If so, the second step assesses whether the claims include elements that transform them into a patent-eligible application[2].

U.S. Patent 10,376,661: Overview

To analyze U.S. Patent 10,376,661, we need to understand its title, abstract, and claims.

Title and Abstract

The title of the patent provides a brief description of the invention. The abstract summarizes the main aspects of the invention, including its purpose and key features.

Claims

The claims section is the most critical part of a patent, as it defines the scope of the invention. There are two types of claims: independent and dependent. Independent claims stand alone and define the invention, while dependent claims refer back to an independent claim and further limit the invention[3].

Analyzing the Claims of U.S. Patent 10,376,661

Independent Claims

Independent claims are broad and define the core of the invention. For example, if U.S. Patent 10,376,661 is related to a new type of software, an independent claim might describe the overall functionality and unique aspects of the software.

Dependent Claims

Dependent claims narrow down the invention by adding specific details or limitations. These claims are often used to protect variations of the invention that are still within the scope of the independent claims.

Patent Scope and Breadth

The scope of a patent is determined by its claims. A broader claim scope can provide more extensive protection but may be more challenging to enforce due to potential overlaps with prior art. The Patent Claims Research Dataset by the USPTO can provide insights into claim scope and breadth by analyzing claim-level statistics and document-level statistics[3].

Global Dossier and International Implications

The Global Dossier service by the USPTO allows users to access file histories of related applications from participating IP Offices. This can be crucial for understanding the international landscape of a patent, including any office actions or citations that may affect the patent's validity or scope[1].

Patent Landscape and Trends

The patent landscape is dynamic, with trends shifting over time. For instance, the number of electrical engineering patents has more than doubled between 2000 and 2018, driven by advancements in information and communication technologies (ICT)[4].

Technology Areas

Patents are classified into various technology areas, such as electrical engineering, mechanical engineering, and chemistry. Understanding these classifications can help in analyzing the competitive landscape and identifying areas of innovation[4].

Geographic Distribution

Patents are allocated geographically based on inventorship information. This data can reveal regional hotspots of innovation and the global distribution of patent activity[4].

Legal and Policy Considerations

Patent Infringement

Patent infringement cases, such as Contour IP Holding LLC v. GoPro, Inc., highlight the importance of precise claim construction and the application of legal tests like the Alice test to determine patent eligibility[2].

Small Claims Patent Court

There is ongoing discussion about establishing a small claims patent court to address the high costs and complexity of patent litigation. This could significantly impact how patent disputes are resolved, especially for smaller entities[5].

Tools and Resources for Patent Search

USPTO Public Search Facility

The USPTO Public Search Facility provides access to patent and trademark information, assisting users in conducting thorough searches and understanding the existing patent landscape[1].

Patent Assignment Search

The Patent Assignment Search website allows users to search for patent assignments and changes in ownership, which is crucial for tracking the legal status of patents[1].

Sequence Listings

For patents involving sequences, such as biotechnology patents, the Publication Site for Issued and Published Sequences (PSIPS) provides access to sequence listings and other relevant data[1].

Key Takeaways

  • Patent Claims: The claims section of a patent defines its scope and is crucial for determining its validity and enforceability.
  • Patent Scope: The breadth of a patent's claims can impact its protection and enforceability.
  • Global Dossier: This service provides access to international patent data, helping in understanding the global patent landscape.
  • Patent Trends: Analyzing trends in patent filings can reveal areas of innovation and competitive landscapes.
  • Legal Considerations: Understanding legal tests like the Alice test and the implications of patent infringement cases is essential for patent holders.

FAQs

What is the purpose of the Alice test in patent law?

The Alice test is used to determine whether patent claims are directed to patent-ineligible subject matter, such as abstract ideas, and whether the claims include elements that transform them into a patent-eligible application.

How do I search for existing patents?

You can search for existing patents using the USPTO Public Search Facility, which provides access to patent and trademark information in various formats.

What is the Global Dossier service?

The Global Dossier service allows users to access file histories of related applications from participating IP Offices, providing a single portal for viewing patent family information and other relevant data.

Why is the classification of patents into technology areas important?

Classifying patents into technology areas helps in analyzing trends in patenting focus over time and understanding the competitive landscape in specific fields.

What is the significance of the Patent Claims Research Dataset?

The Patent Claims Research Dataset provides detailed information on claims from U.S. patents and applications, helping in analyzing claim scope, breadth, and other statistical measures of patent activity.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,376,661

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sumitomo Pharma Am LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 DISCN Yes No 10,376,661 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,376,661

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
12184036Sep 12, 2012
PCT Information
PCT FiledSeptember 09, 2013PCT Application Number:PCT/EP2013/068592
PCT Publication Date:March 20, 2014PCT Publication Number: WO2014/040947

International Family Members for US Patent 10,376,661

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2883583 ⤷  Subscribe
China 104619303 ⤷  Subscribe
European Patent Office 2708219 ⤷  Subscribe
European Patent Office 2895136 ⤷  Subscribe
Spain 2740549 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 2014040947 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.